Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Gain (Loss) on Extinguishment of Debt

2.5 / 5 stars · 59/119 Roast Me

INFUSYSTEM HOLDINGS, INC Gain (Loss) on Extinguishment of Debt

INFUSYSTEM HOLDINGS, INC (INFU) reported Gain (Loss) on Extinguishment of Debt of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2017-05-15

  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for the quarter ending 2017-03-31 was $0.00.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for the quarter ending 2015-12-31 was $0.00.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for the quarter ending 2015-09-30 was $0.00.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for the quarter ending 2015-06-30 was $0.00.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for fiscal 2015 was -$1.60M.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for fiscal 2012 was -$671.00K.
  • INFUSYSTEM HOLDINGS, INC gain (loss) on extinguishment of debt for fiscal 2010 was $1.12M.
Period endGain (Loss) on Extinguishment of Debt 3 monthGain (Loss) on Extinguishment of Debt 6 monthGain (Loss) on Extinguishment of Debt 9 monthGain (Loss) on Extinguishment of Debt 12 month
2017-03-31$0.00
10-Q · filed 2017-05-15
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
$0.00
derived: sum of 2 quarters · filed 2017-03-22
$0.00
derived: sum of 3 quarters · filed 2017-03-22
-$1.60M
10-K · filed 2017-03-22
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12
$0.00
derived: sum of 2 quarters · filed 2016-12-12
-$1.60M
10-Q · filed 2016-12-12
2015-06-30$0.00
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-12-12
-$1.60M
10-Q/A · filed 2016-12-12
2015-03-31-$1.60M
10-Q/A · filed 2016-12-12
2012-12-31-$119.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
-$119.00K
derived: sum of 2 quarters · filed 2014-03-11
-$671.00K
derived: sum of 3 quarters · filed 2014-03-11
-$671.00K
10-K · filed 2014-03-11
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$552.00K
derived: sum of 2 quarters · filed 2013-11-12
-$552.00K
10-Q · filed 2013-11-12
2012-06-30-$552.00K
10-Q · filed 2013-08-13
-$552.00K
10-Q · filed 2013-08-13
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16
$0.00
derived: sum of 2 quarters · filed 2012-03-16
$1.12M
derived: sum of 3 quarters · filed 2012-03-16
$1.12M
10-K · filed 2012-03-16
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$1.12M
derived: sum of 2 quarters · filed 2011-11-14
$1.12M
10-Q · filed 2011-11-14
2010-06-30$1.12M
10-Q · filed 2011-08-15
$1.12M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37